Please provide your email address to receive an email when new articles are posted on . Patient registries have shown that PK rates for keratoconus decreased after the introduction of cross-linking.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Most eyes with keratoconus or corneal ectasia after ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal ...

There is no cure for keratoconus, but the cornea can be strengthened to slow or halt the progression of the disease with an FDA-approved cross-linking procedure called iLink®. Once diagnosed, there is ...

FDA approvals in 2025 introduced novel therapies and devices across ophthalmic subspecialties, emphasizing sustained efficacy ...

FARGO-Good vision is important to Justin Carlson. The 36-year-old Hendricks, Minn., resident performs cardiac ultrasounds for a living, but over the last decade, his corneas have been getting weaker ...

Epioxa Provides the Ophthalmic Community and Patients with the First and Only FDA-Approved, Incision-Free, Topical Drug Therapy for Keratoconus Epioxa Represents a Novel, Groundbreaking Therapy for ...